Austin, April 14, 2025 (GLOBE NEWSWIRE) -- Comprehensive Metabolic Panel Testing Market Size & Growth Analysis: According to a new report by SNS Insider, the Comprehensive Metabolic Panel (CMP) ...

Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center Of the 582 surveys sent, ...

The CMP testing market is fueled by increasing awareness of preventive healthcare and early detection of metabolic disorders. Chronic conditions such as diabetes, kidney diseases, and liver ailments, ...

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its BioCode ® Gastrointestinal Pathogen ...

Germline genetic testing identifies pathogenic variants present at birth that increase the risk of developing ovarian cancer. It also identifies the risk of developing other cancers and, for adults ...